カリフォルニア州における多発性硬化症の臨床試験
カリフォルニア州内の拠点で、多発性硬化症に関する24件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Fresno
- TG Therapeutics Investigational Trial Site, Newport Beach
- TG Therapeutics Investigational Trial Site, Orange
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/23更新 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT07477639Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood
被験者募集中第3相
18歳〜60歳 · 全性別 · 2026/09/15更新 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0114, Loma Linda
- University of California Davis Health, Sacramento
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/09/10更新 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06680037A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/08/14更新 · NCT07304154Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
被験者募集中観察研究健康なボランティア歓迎
18歳〜64歳 · 女性 · 2026/08/11更新 · NCT06940323A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/07/29更新 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
被験者募集中第1/2相
18歳〜55歳 · 全性別 · 2026/07/02更新 · NCT05359653Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
- Byers Hall, San Francisco
被験者募集中第2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/08更新 · NCT07510607Care in Multiple Sclerosis (MS)
- University of California, San Francisco, San Francisco
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/05更新 · NCT07011914ECoG BMI for Motor and Speech Control
- University of California San Francisco, San Francisco
被験者募集中
21歳以上 · 全性別 · 2026/05/05更新 · NCT03698149Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/03/23更新 · NCT07139743Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- University of California San Francisco, San Francisco
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/03/11更新 · NCT02521311A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT06138132Central Vein Sign in Multiple Sclerosis Extension Study
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中
18歳〜65歳 · 全性別 · 2026/02/20更新 · NCT07424027"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
被験者募集中観察研究
18歳以上 · 全性別 · 2025/10/31更新 · NCT07222618Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
被験者募集中第1/2相健康なボランティア歓迎
18歳〜80歳 · 全性別 · 2025/05/02更新 · NCT05395624Kesimpta (Ofatumumab) Pregnancy Registry
- University of California San Diego OTIS, La Jolla
被験者募集中観察研究健康なボランティア歓迎
18歳〜100歳 · 全性別 · 2025/01/14更新 · NCT05634967Entire-body PET Scans for Multiple Sclerosis
- Brain Health Alliance, Ladera Ranch
被験者募集中早期第1相健康なボランティア歓迎
25歳〜55歳 · 全性別 · 2025/01/07更新 · NCT04390009Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- Novartis Investigative Site, La Jolla
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 女性 · 2024/05/16更新 · NCT04933552MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中観察研究健康なボランティア歓迎参加者への支払いあり
18歳以上 · 全性別 · 2024/02/06更新 · NCT05204459ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。